-
-
MyHep All by Mylan in Russia:
In general, Mylan Pharmaceuticals Private Limited (a subsidiary of Mylan N.V.) is the global pharmaceutical company that has introduces a generic version of Velpatasvir and Sofosbuvir combination of medicine for the treatment of Hepatitis-C in Indian market. Mylan is considered as one of the most popular company in India which provides high-quality generic Hep C medicines which are helpful for the treatment of Hepatitis C and other chronic diseases. Velpatasvir 100 mg/ Sofosbuvir 400 mg combination product is sold by Gilead Sciences under the brand name Epclusa. Mylan Launched MyHep All in India for a pack of 28 tablets under the official licensing agreement with Gilead. Other names for the combination medicine Velpatasvir / Sofosbuvir: Sofosvel, Velpanat, Velasof, Velpaclear, Virvel, Resof Total and Sovihep V.
MyHep All is basically a copy of Epclusa – A real International medicine that is considered as an innovative direct-acting antiviral drug (DAA) without any side effects. Basically, it will work in the body by removing the entire Hepatitis C virus from the blood. Read more..
-
You must be logged in to post a comment.